For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
231
views
8
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    3
    shares
      112
      similar
       All similar
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Poster: found
      Is Open Access

      Emerging Therapeutic Approaches in the Treatment of Neurological Symptoms of Friedreich’s Ataxia: A 40-Year Global Perspective

      Published
      poster
      Bookmark

            Abstract

            Content

            Author and article information

            Journal
            Title: ScienceOpen Posters
            Publisher: ScienceOpen
            Publication date (Electronic preprint): 4 August 2024
            Affiliations
            [1 ] University of Southern California;
            [2 ] Think Neuro, Inc.;
            [3 ] University of Texas at Dallas;
            [4 ] Northwestern University ;
            Author notes
            Author information
            https://orcid.org/0009-0008-4324-6074
            https://orcid.org/0009-0007-8818-3815
            https://orcid.org/0009-0000-6311-0192
            https://orcid.org/0009-0004-6367-021X
            https://orcid.org/0009-0008-1646-3858
            https://orcid.org/0009-0005-6879-6513
            https://orcid.org/0009-0006-8749-2205
            https://orcid.org/0009-0008-2722-6612
            Article
            DOI: 10.14293/P2199-8442.1.SOP-.PUQRHI.v1
            SO-VID: b5f3dda7-85f3-4008-a314-926b438682aa
            License:

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            Date received : 4 August 2024
            Categories

            Data availability: The data that support the findings of this study are available from Clarivate™ (Web of Science™) but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Clarivate™ (Web of Science™).
            ScienceOpen disciplines: Medicine,Psychology,Neurology,Genetics
            Keywords: friedreich’s ataxia,frataxin deficiency ,bibliometric analysis,erythropoietin,iron chelators,vitamin E,omaveloxolone,coenzyme Q10,FXN ,FA

            References

            1. Palau Francesc. Friedreich's ataxia and frataxin: Molecular genetics, evolution and pathogenesis (Review). International Journal of Molecular Medicine. 2001. Spandidos Publications. [Cross Ref]

            2. Santos Renata, Lefevre Sophie, Sliwa Dominika, Seguin Alexandra, Camadro Jean-Michel, Lesuisse Emmanuel. Friedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities. Antioxidants & Redox Signaling. Vol. 13(5):651–690. 2010. Mary Ann Liebert Inc. [Cross Ref]

            3. Dusek Petr, Schneider Susanne A., Aaseth Jan. Iron chelation in the treatment of neurodegenerative diseases. Journal of Trace Elements in Medicine and Biology. Vol. 38:81–92. 2016. Elsevier BV. [Cross Ref]

            4. Boesch Sylvia, Sturm Brigitte, Hering Sascha, Scheiber‐Mojdehkar Barbara, Steinkellner Hannes, Goldenberg Hans, Poewe Werner. Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: A clinical pilot trial. Movement Disorders. Vol. 23(13):1940–1944. 2008. Wiley. [Cross Ref]

            5. Cooper J. M., Schapira A. H. V.. Friedreich's Ataxia: Disease mechanisms, antioxidant and Coenzyme Q<sub>10</sub> therapy. BioFactors. Vol. 18(1-4):163–171. 2003. Wiley. [Cross Ref]

            6. Lynch David R., Chin Melanie P., Delatycki Martin B., Subramony S. H., Corti Manuela, Hoyle J. Chad, Boesch Sylvia, Nachbauer Wolfgang, Mariotti Caterina, Mathews Katherine D., Giunti Paola, Wilmot George, Zesiewicz Theresa, Perlman Susan, Goldsberry Angie, O'Grady Megan, Meyer Colin J.. Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (<scp>MOXIe</scp> Study). Annals of Neurology. Vol. 89(2):212–225. 2021. Wiley. [Cross Ref]

            7. Piguet Françoise, de Montigny Charline, Vaucamps Nadège, Reutenauer Laurence, Eisenmann Aurélie, Puccio Hélène. Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia. Molecular Therapy. Vol. 26(8):1940–1952. 2018. Elsevier BV. [Cross Ref]

            8. Aria Massimo, Cuccurullo Corrado. bibliometrix : An R-tool for comprehensive science mapping analysis. Journal of Informetrics. Vol. 11(4):959–975. 2017. Elsevier BV. [Cross Ref]

            Comments

            Comment on this article